Published in Brain on March 17, 2010
Parkinson's disease: the quintessential neuropsychiatric disorder. Mov Disord (2011) 1.62
Nonmotor symptoms in Parkinson's disease in 2012: relevant clinical aspects. Parkinsons Dis (2012) 1.12
Impulse control disorders in Parkinson's disease: recent advances. Curr Opin Neurol (2011) 1.11
Extrastriatal dopaminergic abnormalities of DA homeostasis in Parkinson's patients with medication-induced pathological gambling: a [11C] FLB-457 and PET study. Neurobiol Dis (2012) 1.05
Apathy and depression: separate factors in Parkinson's disease. J Int Neuropsychol Soc (2011) 1.02
A 5-year prospective assessment of advanced Parkinson disease patients treated with subcutaneous apomorphine infusion or deep brain stimulation. J Neurol (2010) 1.01
Dopamine reverses reward insensitivity in apathy following globus pallidus lesions. Cortex (2012) 0.95
STN vs. GPi Deep Brain Stimulation: Translating the Rematch into Clinical Practice. Mov Disord Clin Pract (2014) 0.90
Loss of dopaminergic nigrostriatal neurons accounts for the motivational and affective deficits in Parkinson's disease. Mol Psychiatry (2013) 0.90
The trajectory of apathy after deep brain stimulation: from pre-surgery to 6 months post-surgery in Parkinson's disease. Parkinsonism Relat Disord (2011) 0.88
Prospective cohort study of impulse control disorders in Parkinson's disease. Mov Disord (2013) 0.88
Impulsivity and apathy in Parkinson's disease. J Neuropsychol (2013) 0.87
Current perspectives on deep brain stimulation for severe neurological and psychiatric disorders. Neuropsychiatr Dis Treat (2015) 0.85
Timing of deep brain stimulation in Parkinson disease: a need for reappraisal? Ann Neurol (2013) 0.84
Substance abuse and movement disorders: complex interactions and comorbidities. Curr Drug Abuse Rev (2012) 0.83
Dopaminergic modulation of emotional conflict in Parkinson's disease. Front Aging Neurosci (2014) 0.83
Management of impulse control disorders in Parkinson's disease: Controversies and future approaches. Mov Disord (2015) 0.82
Nonmotor outcomes in Parkinson's disease: is deep brain stimulation better than dopamine replacement therapy? Ther Adv Neurol Disord (2012) 0.82
Mechanisms of body weight fluctuations in Parkinson's disease. Front Neurol (2014) 0.82
Dopamine dysregulation syndrome and deep brain stimulation of the subthalamic nucleus in Parkinson's disease. Neurol Res Int (2011) 0.81
Psychological well-being and regional brain amyloid and tau in mild cognitive impairment. Am J Geriatr Psychiatry (2013) 0.81
Imaging of Dopamine in PD and Implications for Motor and Neuropsychiatric Manifestations of PD. Front Neurol (2013) 0.81
Nonmotor Symptoms and Subthalamic Deep Brain Stimulation in Parkinson's Disease. J Mov Disord (2015) 0.80
Impulse control disorders in Parkinson's disease: background and update on prevention and management. Neurodegener Dis Manag (2012) 0.79
Movement disorders in 2010: Parkinson disease-symptoms and treatments. Nat Rev Neurol (2011) 0.79
Dopamine agonist withdrawal syndrome and non-motor symptoms after Parkinson's disease surgery. Brain (2010) 0.79
Implication of dopamine D3 receptor activation in the reversion of Parkinson's disease-related motivational deficits. Transl Psychiatry (2014) 0.78
Monoamine reuptake inhibitors in Parkinson's disease. Parkinsons Dis (2015) 0.78
The impact of deep brain stimulation on the nonmotor symptoms of Parkinson's disease. J Neural Transm (Vienna) (2012) 0.78
Reward sensitivity deficits modulated by dopamine are associated with apathy in Parkinson's disease. Brain (2016) 0.78
Deep brain stimulation of the subthalamic nucleus improves sense of well-being in Parkinson's disease. Mov Disord (2012) 0.77
Depression, anxiety, and apathy in Parkinson's disease: insights from neuroimaging studies. Eur J Neurol (2016) 0.77
What can rodent models tell us about apathy and associated neuropsychiatric symptoms in Parkinson's disease? Transl Psychiatry (2016) 0.77
Social behavioral changes in MPTP-treated monkey model of Parkinson's disease. Front Behav Neurosci (2015) 0.77
Cognitive and Psychiatric Effects of STN versus GPi Deep Brain Stimulation in Parkinson's Disease: A Meta-Analysis of Randomized Controlled Trials. PLoS One (2016) 0.76
Deep Brain Stimulation in Neurological and Psychiatric Disorders. Dtsch Arztebl Int (2015) 0.76
Decreasing Striatopallidal Pathway Function Enhances Motivation by Energizing the Initiation of Goal-Directed Action. J Neurosci (2016) 0.76
Neural and behavioral substrates of subtypes of Parkinson's disease. Front Syst Neurosci (2013) 0.76
Dopamine and the biology of creativity: lessons from Parkinson's disease. Front Neurol (2014) 0.76
Maladaptive reward-learning and impulse control disorders in patients with Parkinson's disease: a clinical overview and pathophysiology update. J Mov Disord (2014) 0.76
Decomposition of abnormal free locomotor behavior in a rat model of Parkinson's disease. Front Syst Neurosci (2013) 0.76
Subthalamic nucleus deep brain stimulation induces impulsive action when patients with Parkinson's disease act under speed pressure. Exp Brain Res (2016) 0.76
Chronic pramipexole treatment increases tolerance for sucrose in normal and ventral tegmental lesioned rats. Front Neurosci (2015) 0.76
Stimulation-Induced Transient Nonmotor Psychiatric Symptoms following Subthalamic Deep Brain Stimulation in Patients with Parkinson's Disease: Association with Clinical Outcomes and Neuroanatomical Correlates. Stereotact Funct Neurosurg (2016) 0.75
Motivational modes and learning in Parkinson's disease. Soc Cogn Affect Neurosci (2014) 0.75
Pre- and post- GPi DBS neuropsychological profiles in a case of X-linked dystonia-Parkinsonism. Clin Neuropsychol (2011) 0.75
Ganser-like syndrome after loss of psychic self-activation syndrome: psychogenic or organic? Arch Clin Neuropsychol (2014) 0.75
Exploring social cognition in patients with apathy following acquired brain damage. BMC Neurol (2014) 0.75
Self-Reported Executive Functioning in Everyday Life in Parkinson's Disease after Three Months of Subthalamic Deep Brain Stimulation. Parkinsons Dis (2015) 0.75
Referring Parkinson's disease patients for deep brain stimulation: a RAND/UCLA appropriateness study. J Neurol (2015) 0.75
Trait Impulsivity and Anhedonia: Two Gateways for the Development of Impulse Control Disorders in Parkinson's Disease? Front Psychiatry (2016) 0.75
Preliminary Evidence of Apathetic-Like Behavior in Aged Vesicular Monoamine Transporter 2 Deficient Mice. Front Hum Neurosci (2016) 0.75
Apathy and Reduced Speed of Processing Underlie Decline in Verbal Fluency following DBS. Behav Neurol (2017) 0.75
High-frequency stimulation of the subthalamic nucleus counteracts cortical expression of major histocompatibility complex genes in a rat model of Parkinson's disease. PLoS One (2014) 0.75
Affective disorders in Parkinson's disease. Curr Opin Neurol (2013) 0.75
Pramipexole induced place preference after L-dopa therapy and nigral dopaminergic loss: linking behavior to transcriptional modifications. Psychopharmacology (Berl) (2016) 0.75
Imaging the Etiology of Apathy, Anxiety, and Depression in Parkinson's Disease: Implication for Treatment. Curr Neurol Neurosci Rep (2017) 0.75
Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson's disease: evidence for dopaminergic basis? NPJ Parkinsons Dis (2017) 0.75
High frequency deep brain stimulation of the subthalamic nucleus versus continuous subcutaneous apomorphine infusion therapy: a review. J Neural Transm (Vienna) (2010) 0.75
A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med (2006) 8.12
Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med (2003) 6.59
Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease. Lancet Neurol (2009) 4.22
Bilateral deep-brain stimulation of the globus pallidus in primary generalized dystonia. N Engl J Med (2005) 3.88
Subthalamic nucleus stimulation in severe obsessive-compulsive disorder. N Engl J Med (2008) 3.52
The cerebellum communicates with the basal ganglia. Nat Neurosci (2005) 3.27
Uncovering the mechanism(s) of action of deep brain stimulation: activation, inhibition, or both. Clin Neurophysiol (2004) 3.22
Parkinson's disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled. J Neurosci (2006) 3.20
LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs. N Engl J Med (2006) 2.93
Retinal vascular caliber and the development of hypertension: a meta-analysis of individual participant data. J Hypertens (2014) 2.83
Current practices in sedation and analgesia for mechanically ventilated critically ill patients: a prospective multicenter patient-based study. Anesthesiology (2007) 2.83
Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study. Lancet Neurol (2008) 2.83
A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease. Brain (2008) 2.65
Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues. Arch Neurol (2010) 2.64
Bilateral, pallidal, deep-brain stimulation in primary generalised dystonia: a prospective 3 year follow-up study. Lancet Neurol (2007) 2.61
Isolation and characterisation of mesenchymal stem cells from adult mouse bone marrow. Exp Cell Res (2004) 2.34
Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms. Lancet Neurol (2009) 2.28
Diagnostic accuracy of ultrasonography in the acute assessment of common thoracic lesions after trauma. Chest (2011) 2.26
Genome-wide association study confirms BST1 and suggests a locus on 12q24 as the risk loci for Parkinson's disease in the European population. Hum Mol Genet (2010) 2.21
Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease. Mov Disord (2010) 2.20
Pain assessment is associated with decreased duration of mechanical ventilation in the intensive care unit: a post Hoc analysis of the DOLOREA study. Anesthesiology (2009) 2.17
Deep brain stimulation for obsessive-compulsive disorder: subthalamic nucleus target. World Neurosurg (2012) 2.17
Non-cardiac surgery in patients with coronary stents: the RECO study. Heart (2011) 2.10
Corticosteroid after etomidate in critically ill patients: a randomized controlled trial. Crit Care Med (2012) 2.05
How does deep brain stimulation work? Present understanding and future questions. J Clin Neurophysiol (2004) 1.91
Bilateral pallidal deep brain stimulation for the treatment of patients with dystonia-choreoathetosis cerebral palsy: a prospective pilot study. Lancet Neurol (2009) 1.87
Reduced thymic output is a major mechanism of immune reconstitution failure in HIV-infected patients after long-term antiretroviral therapy. Clin Infect Dis (2011) 1.82
NF1 is a tumor suppressor in neuroblastoma that determines retinoic acid response and disease outcome. Cell (2010) 1.81
A major determinant for binding and aminoacylation of tRNA(Ala) in cytoplasmic Alanyl-tRNA synthetase is mutated in dominant axonal Charcot-Marie-Tooth disease. Am J Hum Genet (2009) 1.80
Deep brain stimulation: preoperative issues. Mov Disord (2006) 1.77
Framingham Stroke Risk Profile and poor cognitive function: a population-based study. BMC Neurol (2008) 1.71
Glaucoma prevalence in Indigenous Australians. Br J Ophthalmol (2010) 1.70
EVAluation of the prognostic value of BARoreflex sensitivity in hypertensive patients: the EVABAR study. J Hypertens (2008) 1.69
Parkin mutations are frequent in patients with isolated early-onset parkinsonism. Brain (2003) 1.68
Treatment of chronic tension-type headache with botulinum toxin A: a randomized, double-blind, placebo-controlled multicenter study. Pain (2004) 1.68
Large-scale screening of the Gaucher's disease-related glucocerebrosidase gene in Europeans with Parkinson's disease. Hum Mol Genet (2010) 1.67
Motor cortex stimulation for refractory neuropathic pain: four year outcome and predictors of efficacy. Pain (2005) 1.61
Methylphenidate for gait hypokinesia and freezing in patients with Parkinson's disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo-controlled trial. Lancet Neurol (2012) 1.61
Two-year follow-up of subthalamic deep brain stimulation in Parkinson's disease. Mov Disord (2003) 1.58
Subthalamic nucleus stimulation is efficacious in patients with Parkinsonism and LRRK2 mutations. Mov Disord (2007) 1.58
Increasing prevalence and low awareness, treatment and control of diabetes mellitus among Chinese adults: the InterASIA study. Diabetes Res Clin Pract (2008) 1.57
Effect of activated protein C on pulmonary blood flow and cytokine production in experimental acute lung injury. Intensive Care Med (2007) 1.57
Subthalamic stimulation-induced forelimb dyskinesias are linked to an increase in glutamate levels in the substantia nigra pars reticulata. J Neurosci (2006) 1.56
Direct-tissue SELDI-TOF mass spectrometry analysis: a new application for clinical proteomics. Clin Chem (2006) 1.55
Deep brain stimulation: neuropsychological and neuropsychiatric issues. Mov Disord (2006) 1.54
Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation. Mov Disord (2006) 1.54
G2019S LRRK2 mutation in French and North African families with Parkinson's disease. Ann Neurol (2005) 1.54
Changes in behavior-related neuronal activity in the striatum during learning. Trends Neurosci (2003) 1.53
Dobutamine-mediated heme oxygenase-1 induction via PI3K and p38 MAPK inhibits high mobility group box 1 protein release and attenuates rat myocardial ischemia/reperfusion injury in vivo. J Surg Res (2013) 1.52
Effects of prone position and positive end-expiratory pressure on lung perfusion and ventilation. Crit Care Med (2008) 1.50
Patterns of bidirectional communication between cortex and basal ganglia during movement in patients with Parkinson disease. J Neurosci (2008) 1.47
Simulation-based evaluation of OSEM iterative reconstruction methods in dynamic brain PET studies. Neuroimage (2007) 1.47
Transcranial Doppler to screen on admission patients with mild to moderate traumatic brain injury. Neurosurgery (2011) 1.45
How much phenotypic variation can be attributed to parkin genotype? Ann Neurol (2003) 1.44
Bilateral subthalamic nucleus stimulation in advanced Parkinson's disease: five year follow-up. J Neurol (2009) 1.43
Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease. Mov Disord (2003) 1.43
Word processing in Parkinson's disease is impaired for action verbs but not for concrete nouns. Neuropsychologia (2007) 1.43
Accuracy of complete compression ultrasound in ruling out suspected deep venous thrombosis in the ambulatory setting. A prospective cohort study. Thromb Haemost (2009) 1.43
C9orf72 repeat expansions are a rare genetic cause of parkinsonism. Brain (2013) 1.42
Deep brain stimulation. Cell Tissue Res (2004) 1.42
Muscarinic receptor upregulation in patients with myocardial infarction: a new paradigm. Circ Cardiovasc Imaging (2009) 1.42